This Week on NeurologyLive® — July 11, 2022
Here's what is coming soon to NeurologyLive®.
FDA Grants Priority Review for Lecanemab, FDA AdComm to Reconvene on AMX0035, Tolebrutinib Trials Suspended Over Safety
Neurology News Network for the week ending July 9, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — July 8, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 8, 2022.
Mount Sinai: Institutional Perspectives in Neurology, Chaired by Stephen Krieger, MD
Chaired by Stephen Krieger, MD, the presentations also feature Mount Sinai experts Erin Beck, MD, PhD; James Sumowski, PhD; and Ilana Katz Sand, MD. [WATCH TIME: 1 hour, 34 minutes]
This Week on NeurologyLive® — July 4, 2022
Ocrelizumab Reduces Thalamic Volume Loss, Cenobamate Shines in C017 Study, Trial of LRRK2 Inhibitor BIIB122 Commences
Neurology News Network for the week ending July 2, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — July 1, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 1, 2022.
This Week on NeurologyLive® — June 27, 2022
AbbVie Submits sNDA for Atogepant in Chronic Migraine, Semorinemab Fails in Phase 2 Prodromal Alzheimer Study, StrivePD Software Gets FDA Greenlight
Neurology News Network for the week ending June 25, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — June 24, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 24, 2022.
This Week on NeurologyLive® — June 20, 2022
Erenumab Outperforms Topiramate in PROs, Atogepant Dose-Dependent With Weight Changes, Vutrisiran FDA-Approved for ATTR Amyloidosis
Neurology News Network for the week ending June 18, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 17, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 17, 2022.
This Week on NeurologyLive® — June 13, 2022
6-Week Natalizumab Dosing Efficacious, MS Cognitive Perceptions, Glatiramer Acetate Depot Shines in Progressive MS
Neurology News Network for the week ending June 11, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 10, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 10, 2022.
This Week on NeurologyLive® — June 6, 2022
NeurologyLive® Friday 5 — June 3, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 3, 2022.
Inaugural Class of Giants of Multiple Sclerosis Announced
The 1st annual awards ceremony was held during the CMSC Annual Meeting in National Harbor, Maryland.
This Week on NeurologyLive® — May 30, 2022
AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant
Neurology News Network for the week ending May 28, 2022.
NeurologyLive® Friday 5 — May 27, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 27, 2022.
This Week on NeurologyLive® — May 23, 2022
Diazepam Increased Time Between Cluster Intervals, Higher Dose Nusinersen Shows Extra Benefit, Lecanemab BLA Submitted
Neurology News Network for the week ending May 21, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 20, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 20, 2022.
This Week on NeurologyLive® — May 16, 2022
Ravulizumab Meets Primary End Point in NMOSD, Dosing Initiated in TRANQUILITY II Study, NIH Launches EBV Vaccine Trial
Neurology News Network for the week ending May 14, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 13, 2022
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 13, 2022.
This Week on NeurologyLive® — May 9, 2022
Risdiplam Shows Safety at 3-Year Period, FDA Issues CRL for AXS-07, Cognitive Tests Improve Responder Profiles in MS
Neurology News Network for the week ending May 7, 2022. [WATCH TIME: 4 minutes]